News

Nearly two-thirds of MS patients showed no signs of disability progression five years after having a stem cell transplant, a ...
U.S. and Chinese researchers appear to have unlocked a novel way to stop T cells from attacking the body in MS and other ...
The MIND diet plan, rich in whole grains, leafy greens, berries, and lean proteins, may improve antioxidant defenses in MS, ...
Talking to children about a parent’s multiple sclerosis diagnosis can help ease fears and keep your kids feeling connected.
Researchers at the Karolinska Institute in Sweden have identified 18 new potential drug targets for treating multiple ...
People with multiple sclerosis have a higher risk of developing dementia than the general population, a meta-analysis reports ...
Celebrating independence can be important when living with multiple sclerosis, columnist Ben Hofmeister writes.
Although it’s well-established that anti-CD20 therapies act mainly by killing B-cells, there hasn’t been much study on how these therapies may impact other cells in the immune system. To learn ...
A multiple sclerosis specialist shares insights on quiet progression, and discusses research and treatments for MS activity without relapses.
In healthy adults, a single low dose of IMP761 continues to be safe and appears to reduce the activity of T-cells, a clinical ...
A trial using PET scans to test the anti-inflammatory drug PIPE-791 finished enrolling healthy volunteers and patients with ...